AWAnnette B. Wysocki

Annette B. Wysocki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Annette B. Wysocki has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Marilyn Bookbinder

    Department of Pain Medicine and Palliative Care at Beth Israel Medical Center, New York, New York

    1 shared publication
  • Marla Stevens-Riley

    Food and Drug Administration, Rockville, MD, USA

    1 shared publication
  • Philip M. Tierno

    Clinical Microbiology Laboratory and Department of Microbiology and Pathology, New York University Medical Center, NY, USA

    1 shared publication
  • Ryan-Claire Wiygul

    Department of Surgery, School of Nursing and School of Medicine, University of Mississippi Medical Center, Jackson, MS, USA

    1 shared publication
  • Sandhya K. Bhalla-Regev

    Clinical Microbiology Laboratory and Department of Microbiology and Pathology, New York University Medical Center, NY, USA

    1 shared publication

Latest Publications

  • Proteolytic Activity by Multiple Bacterial Species Isolated From Chronic Venous Leg Ulcers Degrades Matrix Substrates

    by Annette B. Wysocki, Sandhya K. Bhalla-Regev, Philip M. Tierno, Marla Stevens-Riley, Ryan-Claire Wiygul

    Background: A major feature of chronic wounds is the loss of tissue, with the exposure of dermal components preventing primary closure and leading to bacterial colonization. Bacterial colonization has been proposed as one of the common underlying pathologies present in chronic wounds. The objective of this exploratory study was to identify bacteria cultured from chronic venous leg ulcers and test for proteolytic activity that degrades matrix substrates. Method: Bacteria were isolated, cultured, and identified from six subjects (average age = 62.8 years) over 2–10 months under an approved protocol using swabs and microbiological culture media. Proteolytic activity against (a) gelatin, (b) an elastin substrate, and (c) a serine/trypsin-sensitive substrate was determined using a colorimetric plate assay with an ELISA plate reader and zymography. Results: We identified 13 bacteria that expressed proteolytic activity against one or more of the tested substrates. Of these, six were Gram-positive (Staphylococcus aureus, Enterococcus faecalis, Staphylococcus epidermidis, Streptococcus agalactiae, Corynebacterium, and Streptococcus bovis) and seven were Gram-negative (Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Morganella morganii, Klebsiella pneumoniae, Bacteroides fragilis, and Serratia marcescens) organisms. Two of these, S. aureus and P. aeruginosa, are recognized wound pathogens. Conclusions: Multiple bacteria species isolated from colonized venous leg ulcers have the capacity to secrete proteases capable of degrading components of the extracellular matrix important for wound healing. Matrix degradation by bacteria may contribute to delays in tissue deposition and repair, suggesting that treatment of chronic wounds should include appropriate management of colonizing bacteria.


  • Implementing Clinical Practice Changes: A Practical Approach

    by Annette B. Wysocki, Marilyn Bookbinder

    Implementing changes in clinical practice is critical for insuring the highest quality patient care. Ideally, changes in clinical practice should be based upon high-quality research findings or so-called evidence-based medicine. The increase in health care expenditures and data on the variance in clinical practices are exerting external pressures on professionals to justify practice patterns and are now tightly linked to reimbursement. As these factors fuel tensions between quality practice and care on one hand and cost on the other, clinicians must increasingly be prepared to justify the processes and resources used to deliver the required care to produce optimal patient outcomes. Continuously monitoring the clinical literature and implementing clinical practice changes, when a sufficient body of evidence exists, will contribute to improved patient outcomes. This involves three practical steps: (a) examining and evaluating the research, (b) gauging the likelihood of success, and (c) recommending and implementing a clinical practice change.